Factors Associated With Major Bleeding Events: Insights From the Rivaroxaban Once-Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

Study Questions:

What factors are associated with major bleeding in atrial fibrillation patients in the ROCKET AF study?